The upside of the vaccine rollout for the companies making shots

May 3, 2021
The resulting goodwill may prove useful to Pfizer and Moderna.
Karen Andersen, who covers biotech at Morningstar, says the potential sale of booster shots to ward off variants of COVID-19 could be profitable for Pfizer and Moderna.
Matic Zorman/Getty Images

Simmering tensions over EU vaccine distribution threaten to boil over

Jan 27, 2021
The 27-nation bloc is battling with manufacturers over its spot in the priority list for receiving COVID vaccines.
Joel Saget/AFP via Getty Images

The cost of "vaccine nationalism": $9 trillion

Jan 26, 2021
With shortfalls in vaccine supplies, countries across the world are concerned about getting their fair share of doses.
A health worker carries syringes to administer Pfizer COVID-19 vaccines at the opening of a new vaccination site at Corsi Houses in Harlem, New York, on Jan. 15.
Kena Betancur/AFP via Getty Images

Could relaxing patents help poorer countries get vaccines faster?

Dec 15, 2020
India, South Africa, and Kenya want to try. The U.S., EU and U.K. aren't interested.
A medical worker administers the Pfizer BioNtech COVID-19 vaccine to a doctor at a hospital in Miami on Dec. 15.
Joe Raedle/Getty Images

Dry ice makers pressed to meet demand for vaccine distribution

Dec 11, 2020
Supercold storage is essential. But Is there enough dry ice to go around as the coronavirus vaccine is shipped around the country?
An employee makes dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, in November.
Saul Loeb/AFP via Getty Images

Vaccine delivery across the country faces complex supply chain challenges

Dec 10, 2020
Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.
A worker prepares boxes of vaccines before shipment at a French pharmaceutical company world distribution center.
Joel Saget/AFP via Getty Images

U.K. is first to green light Pfizer-BioNTech COVID-19 vaccine

Dec 2, 2020
Fifty U.K. hospitals are on standby to administer vaccine shots, which will be available by next week.
U.K. regulators were the first in the world to approve the coronavirus vaccine made by Pfizer and BioNTech for widespread use.
Vincent Kalut/Photonews via Getty Images

The future is bright… let’s make it even brighter together.

Be a Marketplace Investor with a donation in any amount today.

AstraZeneca vaccine is third to show promising data in unprecedented hurry-up race

Nov 23, 2020
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.
A volunteer receives a COVID-19 vaccination at the Research Centers of America in Hollywood, Florida.
Chandan Khanna/AFP via Getty Images

Pfizer to ask today for emergency vaccine authorization

Emergency authorization means the FDA facilitates availability of the vaccine during a declared state of emergency.
An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes with the logo of pharmaceutical company Pfizer, on Nov. 17, 2020.
Justin Tallis/AFP via Getty Images

How might COVID-19 vaccine makers compete in the marketplace?

Nov 17, 2020
At first, COVID-19 vaccines won't be marketed in the usual sense, because the government will be the main buyer.
A volunteer takes part in a COVID-19 vaccination trial this summer in Hollywood, Florida.
Joe Raedle/Getty Images